(3AR,4R,5R,6AS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-4-(3-三氟甲基)苯氧基-1-丁烯基]-2H-环戊并[B]呋喃-2-酮结构式
|
常用名 | (3AR,4R,5R,6AS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-4-(3-三氟甲基)苯氧基-1-丁烯基]-2H-环戊并[B]呋喃-2-酮 | 英文名 | Fluprostenol Lactone Diol |
|---|---|---|---|---|
| CAS号 | 53872-60-9 | 分子量 | 372.336 | |
| 密度 | 1.4±0.1 g/cm3 | 沸点 | 520.6±50.0 °C at 760 mmHg | |
| 分子式 | C18H19F3O5 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 268.6±30.1 °C |
| 中文名 | (+)-(3aR,4R,5r,6aS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-4-(3-三氟甲基)苯氧基-1-丁烯基]-2H-环戊并[b]呋喃-2-酮 |
|---|---|
| 英文名 | (3aR,4R,5R,6aS)-5-hydroxy-4-[(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one |
| 中文别名 | 2H-环戊并[B]呋喃-2-酮,六氢-5-羟基-4-[(1E,3R)-3-羟基-4-[3-(三氟甲基)苯氧基]-1-丁烯-1-基]-,(3AR,4R,5R,6AS)- | (+)-(3AR,4R,5R,6AS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-4-(3-三氟甲基)苯氧基-1-丁烯基]-2H-环戊并[B]呋喃-2-酮 | 曲沃前列素中间体 |
| 英文别名 | 更多 |
| 密度 | 1.4±0.1 g/cm3 |
|---|---|
| 沸点 | 520.6±50.0 °C at 760 mmHg |
| 分子式 | C18H19F3O5 |
| 分子量 | 372.336 |
| 闪点 | 268.6±30.1 °C |
| 精确质量 | 372.118469 |
| PSA | 75.99000 |
| LogP | 1.05 |
| InChIKey | XYSPYIAAWRUEML-UHFFFAOYSA-N |
| SMILES | O=C1CC2C(CC(O)C2C=CC(O)COc2cccc(C(F)(F)F)c2)O1 |
| 蒸汽压 | 0.0±1.4 mmHg at 25°C |
| 折射率 | 1.583 |
| 储存条件 | -20°C |
| 危害码 (欧洲) | Xn |
|---|
|
~%
(3AR,4R,5R,6AS)... 53872-60-9 |
| 文献:WO2011/46569 A1, ; Page/Page column 67-68 ; |
|
~%
(3AR,4R,5R,6AS)... 53872-60-9 |
| 文献:Journal of Medicinal Chemistry, , vol. 24, # 11 p. 1353 - 1359 |
|
~%
(3AR,4R,5R,6AS)... 53872-60-9 |
| 文献:Journal of Medicinal Chemistry, , vol. 24, # 11 p. 1353 - 1359 |
|
~%
(3AR,4R,5R,6AS)... 53872-60-9 |
| 文献:Journal of Medicinal Chemistry, , vol. 24, # 11 p. 1353 - 1359 |
|
~%
(3AR,4R,5R,6AS)... 53872-60-9 |
| 文献:Journal of Medicinal Chemistry, , vol. 24, # 11 p. 1353 - 1359 |
|
~%
(3AR,4R,5R,6AS)... 53872-60-9 |
| 文献:WO2013/164729 A1, ; |
| Travoprost Intermediate |
| 2H-Cyclopenta[b]furan-2-one, hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-, (3aS,4R,5R,6aR)- |
| (3aR,4R,5R,6aS)-5-Hydroxy-4-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}hexahydro-2H-cyclopenta[b]furan-2-one |
| (3aR,4R,5R,6aS)-5-Hydroxy-4-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one |
| (3aR,4R,5R,6aS)-5-hydroxy-4-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-enyl)hexahydro-2H-cyclopenta[b]furan-2-one |
| (3aR,4R,5R,6aS)-5-Hydroxy-4-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl}hexahydro-2H-cyclopenta[b]furan-2-one |
| (3aS,4R,5R,6aR)-5-Hydroxy-4-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl}hexahydro-2H-cyclopenta[b]furan-2-one |
| 2H-Cyclopenta[b]furan-2-one, hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-, (3aR,4R,5R,6aS)- |